Literature DB >> 11959798

Activity profile of calpains I and II in chronically infarcted rat myocardium--influence of the calpain inhibitor CAL 9961.

Steffen Sandmann1, Freerk Prenzel, Lee Shaw, Roland Schauer, Thomas Unger.   

Abstract

1. The calpains have been proposed to be activated following cardiac ischaemia and to contribute to myocyte damage after myocardial infarction (MI). In this study, the activity of calpains I and II in the infarcted and non-infarcted rat myocardium and the action of the selective calpain inhibitor, CAL 9961, has been investigated. 2. MI was induced by permanent ligation of the left coronary artery. One, 3, 7 and 14 days post MI, the enzymes calpain I and II were separated from homogenates of the interventricular septum (IS) and left ventricular free wall (LVFW) by chromatography on DEAE-Sepharose. The activity of the calpains was measured in sham-operated and MI animals chronically treated with placebo or CAL 9961 (15 mg kg(-1) d(-1) s.c.) in a synthetic substrate assay. Treatment was started 3 days before MI induction. 3. Calpain I activity reached highest values in IS 14 days post MI, whereas maximum activity of calpain II was measured in LVFW 3 days post MI. In experiments in vitro, CAL 9961 completely inhibited both calpains. In vivo, chronic treatment of MI animals with CAL 9961 partially prevented the increase in calpain I activity in IS and reduced calpain II activity in LVFW to sham levels. 4. Our findings demonstrate that calpains I and II are activated after MI, however, both enzymes differ in their regional and temporal activation within the infarcted myocardium. Chronic inhibition of these enzymes with CAL 9961 might limit the calpain-induced myocardial damage and preserve cardiac structural integrity post MI.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11959798      PMCID: PMC1573324          DOI: 10.1038/sj.bjp.0704661

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  Calpain inhibitor I reduces the development of acute and chronic inflammation.

Authors:  S Cuzzocrea; M C McDonald; E Mazzon; D Siriwardena; I Serraino; L Dugo; D Britti; G Mazzullo; A P Caputi; C Thiemermann
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction--effects of AT(1) and AT(2) receptor antagonists and ACE inhibitor.

Authors:  S Sandmann; M Yu; T Unger
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

4.  Effects of the calcium channel antagonist mibefradil on haemodynamic parameters and myocardial Ca(2+)-handling in infarct-induced heart failure in rats.

Authors:  S Sandmann; J Y Min; A Meissner; T Unger
Journal:  Cardiovasc Res       Date:  1999-10       Impact factor: 10.787

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Canine cardiac calcium-dependent proteases: Resolution of two forms with different requirements for calcium.

Authors:  R L Mellgren
Journal:  FEBS Lett       Date:  1980-01-01       Impact factor: 4.124

7.  Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies.

Authors:  B O'Rourke; D A Kass; G F Tomaselli; S Kääb; R Tunin; E Marbán
Journal:  Circ Res       Date:  1999-03-19       Impact factor: 17.367

8.  Enhanced Ca(2+) release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: potential link between contractile adaptation and arrhythmogenesis.

Authors:  K R Sipido; P G Volders; S H de Groot; F Verdonck; F Van de Werf; H J Wellens; M A Vos
Journal:  Circulation       Date:  2000-10-24       Impact factor: 29.690

9.  Reduction of experimentally produced acute myocardial infarction size by a new synthetic inhibitor, NCO-700, against calcium-activated neutral protease.

Authors:  T Toyo-oka; T Kamishiro; M Masaki; T Masaki
Journal:  Jpn Heart J       Date:  1982-09

Review 10.  Calcium entry in the calcium paradox.

Authors:  P M Grinwald; W G Nayler
Journal:  J Mol Cell Cardiol       Date:  1981-10       Impact factor: 5.000

View more
  12 in total

Review 1.  Tear me down: role of calpain in the development of cardiac ventricular hypertrophy.

Authors:  Cam Patterson; Andrea L Portbury; Jonathan C Schisler; Monte S Willis
Journal:  Circ Res       Date:  2011-08-05       Impact factor: 17.367

Review 2.  Calpain system and its involvement in myocardial ischemia and reperfusion injury.

Authors:  Christiane Neuhof; Heinz Neuhof
Journal:  World J Cardiol       Date:  2014-07-26

Review 3.  Calpain research for drug discovery: challenges and potential.

Authors:  Yasuko Ono; Takaomi C Saido; Hiroyuki Sorimachi
Journal:  Nat Rev Drug Discov       Date:  2016-11-11       Impact factor: 84.694

4.  Receptor-independent cardiac protein kinase Calpha activation by calpain-mediated truncation of regulatory domains.

Authors:  Min-Young Kang; Yan Zhang; Scot J Matkovich; Abhinav Diwan; Athar H Chishti; Gerald W Dorn
Journal:  Circ Res       Date:  2010-08-05       Impact factor: 17.367

5.  Calpain inhibition preserves myocardial structure and function following myocardial infarction.

Authors:  Santhosh K Mani; Sundaravadivel Balasubramanian; Juozas A Zavadzkas; Laura B Jeffords; William T Rivers; Michael R Zile; Rupak Mukherjee; Francis G Spinale; Dhandapani Kuppuswamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-04       Impact factor: 4.733

Review 6.  Calpains as Potential Therapeutic Targets for Myocardial Hypertrophy.

Authors:  David Aluja; Sara Delgado-Tomás; Marisol Ruiz-Meana; José A Barrabés; Javier Inserte
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

7.  Calpain-dependent cleavage of N-cadherin is involved in the progression of post-myocardial infarction remodeling.

Authors:  Yoko Kudo-Sakamoto; Hiroshi Akazawa; Kaoru Ito; Jiro Takano; Masamichi Yano; Chizuru Yabumoto; Atsuhiko T Naito; Toru Oka; Jong-Kook Lee; Yasushi Sakata; Jun-ichi Suzuki; Takaomi C Saido; Issei Komuro
Journal:  J Biol Chem       Date:  2014-06-02       Impact factor: 5.157

8.  Expression of vascular endothelial growth factor and transcription factors HIF-1, NF-kB expression in squamous cell carcinoma of head and neck; association with proteasome and calpain activities.

Authors:  Liudmila V Spirina; Irina V Kondakova; Evgeny L Choynzonov; Svetlana Y Chigevskaya; Dmitry A Shishkin; Denis Y Kulbakin
Journal:  J Cancer Res Clin Oncol       Date:  2012-12-27       Impact factor: 4.553

9.  Targeting Calpain for Heart Failure Therapy: Implications From Multiple Murine Models.

Authors:  Yihui Wang; Biyi Chen; Chun-Kai Huang; Ang Guo; Jennifer Wu; Xiaoming Zhang; Rong Chen; Cheng Chen; William Kutschke; Robert M Weiss; Ryan L Boudreau; Kenneth B Margulies; Jiang Hong; Long-Sheng Song
Journal:  JACC Basic Transl Sci       Date:  2018-08-28

10.  Expression of calcineurin, calpastatin and heat shock proteins during ischemia and reperfusion.

Authors:  Sreejit Parameswaran; Rajendra K Sharma
Journal:  Biochem Biophys Rep       Date:  2015-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.